Learn article
A source-evaluation and consultation framework for beginning limb-lengthening research, emphasizing study design, regulator records, current device information, claim logs, and unresolved uncertainty.
Define the question first: indication, candidate evaluation, segment, amount, method, outcomes, risk, rehabilitation, remote care, or cost. A source is useful only when its population, procedure, date, and outcome match the question closely enough.
Check whether they studied different patients, devices, definitions, countries, eras, or endpoints. A provider protocol can differ from a study without either being fraudulent, but the provider should explain the rationale and evidence. Current regulator information overrides an older availability or recall statement.
A length, complication rate, healing index, satisfaction percentage, or return date must retain its denominator, population, method, timepoint, and uncertainty. Published averages are descriptions, not personalized targets.
Device status, recalls, provider credentials, facility affiliation, prices, insurance, and travel rules can change. Record the date and verify again near consent and surgery. The FDA currently states that stainless-steel Precice devices including STRYDE remain recalled; PRECICE MAX also has an open Class II recall as of July 12, 2026. [1][2]
Current U.S. indications, weight and implant-count limits, one-year removal instruction, and stainless-steel device recall status.
Recall initiated September 30, 2024. The FDA record was open when reviewed on July 12, 2026.
Informational only. Not medical advice.